Scholar Rock Holding SRRK
NASDAQ SRRK
$55.52 -0.42 (-0.75%)
As of: Sep 4, 2026 · 2:25 PM EDT

Scholar Rock Holding (SRRK) Share-based Compensation (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Share-based Compensation of $204.5 million for Q1 2026, up 1424.53% year-over-year from $13.4 million in Q1 2025, and up 952.8% quarter-over-quarter from $19.4 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Share-based Compensation (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Share-based Compensation history runs 10 years deep, the most recent figure standing at $204.5 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 1424.53% year-over-year to $204.5 million; the TTM figure through Mar 2026 stood at $204.5 million (up 388.3% YoY), while the FY2025 annual figure was $153.7 million, up 98.56% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $204.5 million, up from $19.4 million in the prior quarter.
  • The five-year high for Share-based Compensation was $204.5 million in Q1 2026, with the low at $6.2 million in Q4 2022.
  • The 5-year median for Share-based Compensation is $8.2 million (2024), against an average of $30.9 million.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation dropped 9.64% in 2023, then jumped 1689.63% in 2025.
  • Scholar Rock Holding's Share-based Compensation stood at $6.2 million in 2022, then rose by 12.75% to $7.0 million in 2023, then jumped by 36.7% to $9.5 million in 2024, then soared by 104.41% to $19.4 million in 2025, then soared by 952.8% to $204.5 million in 2026.
  • Business Quant data shows SRRK's Share-based Compensation at $204.5 million in Q1 2026, $19.4 million in Q4 2025, and $172.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn - 277.20 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 41.25 Mn
10 Scholar Rock Holding 7.26 Bn 7.26 Bn - 194.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 194.21 Mn
Mar 31, 2026 18.25 Mn
Dec 31, 2025 19.42 Mn
Sep 30, 2025 172.70 Mn
Jun 30, 2025 24.43 Mn
Mar 31, 2025 13.41 Mn
Dec 31, 2024 9.50 Mn
Sep 30, 2024 9.67 Mn
Jun 30, 2024 9.31 Mn
Mar 31, 2024 9.05 Mn
Dec 31, 2023 6.95 Mn
Sep 30, 2023 7.42 Mn
Jun 30, 2023 7.84 Mn
Mar 31, 2023 7.54 Mn
Dec 31, 2022 6.17 Mn
Sep 30, 2022 7.92 Mn
Jun 30, 2022 1.00 Bn
Mar 31, 2022 6.83 Mn
Dec 31, 2021 6.10 Mn
Sep 30, 2021 6.15 Mn